KSHV-associated and EBV-associated Germinotropic Lymphoproliferative Disorder New Findings and Review of the Literature

被引:28
|
作者
Bhavsar, Tapan [1 ]
Lee, John C. [2 ]
Perner, Yvonne [3 ]
Raffeld, Mark [1 ]
Xi, Liqiang [1 ]
Pittaluga, Stefania [1 ]
Jaffe, Elaine S. [1 ]
机构
[1] NCI, Hematopathol Sect, Pathol Lab, Ctr Canc Res,NIH, Bldg 10,Room 3S235, Bethesda, MD 20892 USA
[2] Boston Univ, Sch Med, Dept Pathol & Lab Med, Boston, MA 02118 USA
[3] Univ Witwatersrand, Dept Pathol, Johannesburg, South Africa
关键词
Kaposi sarcoma herpes virus; HHV-8; Epstein Barr virus; Castleman disease; germinotropic; SARCOMA-ASSOCIATED HERPESVIRUS; PRIMARY EFFUSION LYMPHOMA; MULTICENTRIC CASTLEMAN-DISEASE; KAPOSIS-SARCOMA; GERMINAL-CENTERS; HODGKIN-LYMPHOMA; CELL LYMPHOMA; INTERLEUKIN-10; KSHV/HHV-8; ENTITY;
D O I
10.1097/PAS.0000000000000823
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
We report 2 cases of Kaposi sarcoma-associated herpesvirus (KSHV)-and Epstein-Barr Virus (EBV) associated germinotropic lymphoproliferative disorder. Both cases arose in patients from regions endemic for KSHV, Cape Verde, and the Democratic Republic of the Congo, presenting as localized lymphadenopathy. The affected lymph nodes showed colonization of the follicles by clusters of large atypical plasmablasts, but also showed regressive changes with vascular proliferation and interfollicular plasmacytosis, both reminiscent of human herpesvirus 8 (HHV-8) positive multicentric Castleman disease. The atypical plasmablasts showed dual positivity for HHV-8 and EBV, being positive for LANA and viral interleukin 6, as well as Epstein-Barr virus-encoded small RNA by in situ hybridization. They showed a latency I phenotype, being negative for LMP1, EBNA2, and BZLF-1. The plasmablasts were negative for immunoglobulin light chains, and in 1 case with successful DNA amplification had a polyclonal immunoglobulin rearrangement pattern. Germinotropic lymphoproliferative disorder is a rare disorder, with only 6 cases reported in the literature. We demonstrate for the first time the expression of HHV8 viral interleukin 6 and provide evidence for latency I phenotype for EBV. In addition, 1 case progressed to an EBV-positive diffuse large B-cell lymphoma, but interestingly was negative for KSHV/HHV-8, likely indicative of tumor derived from an independent clone.
引用
收藏
页码:795 / 800
页数:6
相关论文
共 50 条
  • [31] New insights into EBV-associated post-transplant lymphoproliferative disease
    Rooney, CM
    LANCET, 2003, 361 (9353): : 192 - 193
  • [32] EPSTEIN-BARR-VIRUS (EBV) LYTIC PROTEINS IN EBV-ASSOCIATED POSTTRANSPLANT LYMPHOPROLIFERATIVE DISORDER (PTLD)
    MONTONE, KT
    SALHANY, KE
    LAVI, E
    HODINKA, R
    TOMASZEWSKI, JE
    LABORATORY INVESTIGATION, 1995, 72 (01) : A117 - A117
  • [36] New concepts in EBV-associated B, T, and NK cell lymphoproliferative disorders
    Quintanilla-Martinez, Leticia
    Swerdlow, Steven H.
    Tousseyn, Thomas
    Barrionuevo, Carlos
    Nakamura, Shigeo
    Jaffe, Elaine S.
    VIRCHOWS ARCHIV, 2023, 482 (01) : 227 - 244
  • [37] New concepts in EBV-associated B, T, and NK cell lymphoproliferative disorders
    Leticia Quintanilla-Martinez
    Steven H Swerdlow
    Thomas Tousseyn
    Carlos Barrionuevo
    Shigeo Nakamura
    Elaine S. Jaffe
    Virchows Archiv, 2023, 482 : 227 - 244
  • [38] Should immunosuppressed IBD patients have routine monitoring of EBV? Two cases of EBV-associated lymphoproliferative disorder
    Subramaniam, Kavitha
    Cherian, Maya
    Latimer, Maya
    D'Rozario, James
    Corbett, Michael
    Pavli, Paul
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2012, 27 : 119 - 119
  • [39] CD27: A new player in the field of common variable immunodeficiency and EBV-associated lymphoproliferative disorder? Reply
    van Montfrans, Joris M.
    Orange, Jordan S.
    Tesselaar, Kiki
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2012, 129 (04) : 1175 - 1176
  • [40] FUNCTIONALITY OF ITK MUTATIONS IN CHILDREN WITH EBV-ASSOCIATED LYMPHOPROLIFERATIVE DISEASES
    Linka, R. M.
    Bienemann, K.
    Risse, S. L.
    Werner, M.
    Linka, Y.
    Krux, F.
    Synaeve, C.
    Deenen, R.
    Dvorsky, R.
    Halenius, A.
    Hartig, R.
    Fischer, A.
    Stepensky, P.
    Vettenranta, K.
    Mahdaviani, S. A.
    Koehrer, K.
    Ahmadian, M. R.
    Laws, H-J.
    Fleckenstein, B.
    Jumaa, H.
    Latour, S.
    Schraven, B.
    Borkhardt, A.
    JOURNAL OF CLINICAL IMMUNOLOGY, 2012, 32 : 21 - 22